(CTS) CTS - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1265011056
Stock: Sensors, Actuators, Resistors, Capacitors, Filters
Total Rating 57
Risk 89
Buy Signal 0.65
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.37% |
| Yield on Cost 5y | 0.49% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 94.3% |
| Payout Ratio | 9.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 32.0% |
| Relative Tail Risk | -7.21% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.53 |
| Alpha | -0.71 |
| Character TTM | |
|---|---|
| Beta | 1.156 |
| Beta Downside | 1.014 |
| Drawdowns 3y | |
|---|---|
| Max DD | 40.62% |
| CAGR/Max DD | 0.18 |
Description: CTS CTS January 18, 2026
CTS Corporation (NYSE:CTS) designs, manufactures, and sells a broad portfolio of sensors, connectivity components, and actuators across North America, Europe, and Asia, serving transportation, industrial, medical, aerospace, and defense customers through a mix of sales engineers, independent representatives, and distributors.
In FY 2023 the company generated roughly $1.1 billion in revenue with an operating margin near 10%, and it reinvests about 5% of sales into R&D to sustain its piezo-technology leadership. Key macro drivers include the accelerating shift to electric and autonomous vehicles, which boosts demand for high-precision sensors and actuators, and ongoing defense budget increases that support aerospace and military procurement. A material risk remains the semiconductor supply-chain bottleneck, which can pressure lead times and component pricing.
For a deeper, data-driven view of CTS’s valuation dynamics, you might explore the analyst tools on ValueRay to see how its metrics compare to sector peers.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 59.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -1.17 > 1.0 |
| NWC/Revenue: 32.24% < 20% (prev 29.59%; Δ 2.65% < -1%) |
| CFO/TA 0.13 > 3% & CFO 98.8m > Net Income 59.2m |
| Net Debt (22.3m) to EBITDA (115.9m): 0.19 < 3 |
| Current Ratio: 2.64 > 1.5 & < 3 |
| Outstanding Shares: last quarter (30.0m) vs 12m ago -1.82% < -2% |
| Gross Margin: 38.10% > 18% (prev 0.35%; Δ 3774 % > 0.5%) |
| Asset Turnover: 67.30% > 50% (prev 64.98%; Δ 2.33% > 0%) |
| Interest Coverage Ratio: 15.61 > 6 (EBITDA TTM 115.9m / Interest Expense TTM 5.24m) |
Altman Z'' 9.45
| A: 0.22 (Total Current Assets 276.2m - Total Current Liabilities 104.8m) / Total Assets 790.4m |
| B: 0.88 (Retained Earnings 694.9m / Total Assets 790.4m) |
| C: 0.10 (EBIT TTM 81.8m / Avg Total Assets 789.9m) |
| D: 4.25 (Book Value of Equity 1.03b / Total Liabilities 242.7m) |
| Altman-Z'' Score: 9.45 = AAA |
Beneish M -3.17
| DSRI: 0.96 (Receivables 85.9m/86.4m, Revenue 531.6m/512.9m) |
| GMI: 0.93 (GM 38.10% / 35.46%) |
| AQI: 0.96 (AQ_t 0.51 / AQ_t-1 0.53) |
| SGI: 1.04 (Revenue 531.6m / 512.9m) |
| TATA: -0.05 (NI 59.2m - CFO 98.8m) / TA 790.4m) |
| Beneish M-Score: -3.17 (Cap -4..+1) = AA |
What is the price of CTS shares?
As of February 07, 2026, the stock is trading at USD 55.78 with a total of 191,488 shares traded.
Over the past week, the price has changed by +8.50%, over one month by +22.54%, over three months by +36.14% and over the past year by +17.68%.
Over the past week, the price has changed by +8.50%, over one month by +22.54%, over three months by +36.14% and over the past year by +17.68%.
Is CTS a buy, sell or hold?
CTS has received a consensus analysts rating of 3.00.
Therefor, it is recommend to hold CTS.
- StrongBuy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CTS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 47 | -15.7% |
| Analysts Target Price | 47 | -15.7% |
| ValueRay Target Price | 58.7 | 5.2% |
CTS Fundamental Data Overview February 02, 2026
P/E Trailing = 26.2296
P/E Forward = 14.3678
P/S = 2.851
P/B = 2.7575
P/EG = 2.05
Revenue TTM = 531.6m USD
EBIT TTM = 81.8m USD
EBITDA TTM = 115.9m USD
Long Term Debt = 90.7m USD (from longTermDebt, last quarter)
Short Term Debt = 19.0m USD (from shortTermDebt, last quarter)
Debt = 132.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 22.3m USD (from netDebt column, last quarter)
Enterprise Value = 1.54b USD (1.52b + Debt 132.6m - CCE 110.3m)
Interest Coverage Ratio = 15.61 (Ebit TTM 81.8m / Interest Expense TTM 5.24m)
EV/FCF = 19.17x (Enterprise Value 1.54b / FCF TTM 80.2m)
FCF Yield = 5.22% (FCF TTM 80.2m / Enterprise Value 1.54b)
FCF Margin = 15.09% (FCF TTM 80.2m / Revenue TTM 531.6m)
Net Margin = 11.13% (Net Income TTM 59.2m / Revenue TTM 531.6m)
Gross Margin = 38.10% ((Revenue TTM 531.6m - Cost of Revenue TTM 329.1m) / Revenue TTM)
Gross Margin QoQ = 38.71% (prev 39.09%)
Tobins Q-Ratio = 1.95 (Enterprise Value 1.54b / Total Assets 790.4m)
Interest Expense / Debt = 0.84% (Interest Expense 1.11m / Debt 132.6m)
Taxrate = 30.59% (6.03m / 19.7m)
NOPAT = 56.8m (EBIT 81.8m * (1 - 30.59%))
Current Ratio = 2.64 (Total Current Assets 276.2m / Total Current Liabilities 104.8m)
Debt / Equity = 0.24 (Debt 132.6m / totalStockholderEquity, last quarter 547.7m)
Debt / EBITDA = 0.19 (Net Debt 22.3m / EBITDA 115.9m)
Debt / FCF = 0.28 (Net Debt 22.3m / FCF TTM 80.2m)
Total Stockholder Equity = 541.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.49% (Net Income 59.2m / Total Assets 790.4m)
RoE = 10.93% (Net Income TTM 59.2m / Total Stockholder Equity 541.7m)
RoCE = 12.93% (EBIT 81.8m / Capital Employed (Equity 541.7m + L.T.Debt 90.7m))
RoIC = 9.00% (NOPAT 56.8m / Invested Capital 630.9m)
WACC = 9.41% (E(1.52b)/V(1.65b) * Re(10.18%) + D(132.6m)/V(1.65b) * Rd(0.84%) * (1-Tc(0.31)))
Discount Rate = 10.18% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.04%
[DCF Debug] Terminal Value 73.44% ; FCFF base≈83.9m ; Y1≈85.5m ; Y5≈94.2m
Fair Price DCF = 43.77 (EV 1.29b - Net Debt 22.3m = Equity 1.27b / Shares 29.1m; r=9.41% [WACC]; 5y FCF grow 1.82% → 2.90% )
EPS Correlation: -27.81 | EPS CAGR: 5.55% | SUE: -0.24 | # QB: 0
Revenue Correlation: -50.37 | Revenue CAGR: 2.04% | SUE: 1.96 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.52 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=2.40 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+8.6% | Growth Revenue=+4.0%
P/E Forward = 14.3678
P/S = 2.851
P/B = 2.7575
P/EG = 2.05
Revenue TTM = 531.6m USD
EBIT TTM = 81.8m USD
EBITDA TTM = 115.9m USD
Long Term Debt = 90.7m USD (from longTermDebt, last quarter)
Short Term Debt = 19.0m USD (from shortTermDebt, last quarter)
Debt = 132.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 22.3m USD (from netDebt column, last quarter)
Enterprise Value = 1.54b USD (1.52b + Debt 132.6m - CCE 110.3m)
Interest Coverage Ratio = 15.61 (Ebit TTM 81.8m / Interest Expense TTM 5.24m)
EV/FCF = 19.17x (Enterprise Value 1.54b / FCF TTM 80.2m)
FCF Yield = 5.22% (FCF TTM 80.2m / Enterprise Value 1.54b)
FCF Margin = 15.09% (FCF TTM 80.2m / Revenue TTM 531.6m)
Net Margin = 11.13% (Net Income TTM 59.2m / Revenue TTM 531.6m)
Gross Margin = 38.10% ((Revenue TTM 531.6m - Cost of Revenue TTM 329.1m) / Revenue TTM)
Gross Margin QoQ = 38.71% (prev 39.09%)
Tobins Q-Ratio = 1.95 (Enterprise Value 1.54b / Total Assets 790.4m)
Interest Expense / Debt = 0.84% (Interest Expense 1.11m / Debt 132.6m)
Taxrate = 30.59% (6.03m / 19.7m)
NOPAT = 56.8m (EBIT 81.8m * (1 - 30.59%))
Current Ratio = 2.64 (Total Current Assets 276.2m / Total Current Liabilities 104.8m)
Debt / Equity = 0.24 (Debt 132.6m / totalStockholderEquity, last quarter 547.7m)
Debt / EBITDA = 0.19 (Net Debt 22.3m / EBITDA 115.9m)
Debt / FCF = 0.28 (Net Debt 22.3m / FCF TTM 80.2m)
Total Stockholder Equity = 541.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.49% (Net Income 59.2m / Total Assets 790.4m)
RoE = 10.93% (Net Income TTM 59.2m / Total Stockholder Equity 541.7m)
RoCE = 12.93% (EBIT 81.8m / Capital Employed (Equity 541.7m + L.T.Debt 90.7m))
RoIC = 9.00% (NOPAT 56.8m / Invested Capital 630.9m)
WACC = 9.41% (E(1.52b)/V(1.65b) * Re(10.18%) + D(132.6m)/V(1.65b) * Rd(0.84%) * (1-Tc(0.31)))
Discount Rate = 10.18% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.04%
[DCF Debug] Terminal Value 73.44% ; FCFF base≈83.9m ; Y1≈85.5m ; Y5≈94.2m
Fair Price DCF = 43.77 (EV 1.29b - Net Debt 22.3m = Equity 1.27b / Shares 29.1m; r=9.41% [WACC]; 5y FCF grow 1.82% → 2.90% )
EPS Correlation: -27.81 | EPS CAGR: 5.55% | SUE: -0.24 | # QB: 0
Revenue Correlation: -50.37 | Revenue CAGR: 2.04% | SUE: 1.96 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.52 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=2.40 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+8.6% | Growth Revenue=+4.0%